News Detail
New Delhi, 3 Jan 2025 (IANS) Immuno-oncology (IO) drugs or cancer therapeutics represent one of the most promising areas of medical innovation in the next five years, according to a report on Friday.
The report by GlobalData, a data and analytics company, base......
View Details
Source : IANS
Immuno-oncology (IO) drugs
cancer therapeutics
medical innovation
GlobalData
Urte Jakimaviciute
Senior Director of Market Research and Strategic Intelligence in the healthcare division at GlobalData
Related News
- Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)
- Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)
- SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)
- 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)